21:21 , Jun 14, 2019 |  BioCentury  |  Product Development

Despite senior management shake-up, Novartis’ pipeline is primed to deliver

A string of departures at Novartis AG and strategic shifts by new CEO Vasant Narasimhan have produced a fairly thorough makeover of the executive committee he inherited in 2018. The team gains a pipeline that...
21:46 , May 24, 2019 |  BC Extra  |  Company News

Novartis on goal to hit mid-30s margins by 2022

Novartis is on track to achieve profit margins in the mid-30s, plans to spend about 5% of market cap per year on M&A and business development and licensing, and will complete a $5 billion share...
23:16 , Apr 16, 2019 |  BC Extra  |  Company News

Management tracks: Ginkgo Bioworks, KSQ, Milestone, Cerebral

Genetic engineering company Ginkgo Bioworks Inc. (Boston, Mass.) appointed Marijn Dekkers as chairman and strategic adviser. He was CEO of Bayer AG (Xetra:BAYN) and is currently chairman of Unilever plc (LSE:ULVR), Unilever N.V. (NYSE:UL) and...
23:22 , Apr 9, 2019 |  BC Extra  |  Company News

IFM Tre deal offers glimpse into Novartis' M&A future

Novartis' acquisition of IFM Tre gives a glimpse of its M&A strategy going forward, as the pharma focuses on early stage deals and aims to keep M&A spending at 5% of market cap. Prakash Raman,...
18:00 , Sep 28, 2018 |  BC Week In Review  |  Company News

Novartis to cut Swiss, U.K. jobs to adapt manufacturing

Novartis AG (NYSE:NVS; SIX:NOVN) revealed restructuring plans that could remove a net of up to 1,700 Swiss-based jobs over four years as the pharma continues to evolve its business services organization and manufacturing strategy, spokesperson...
16:42 , Jul 20, 2018 |  BC Week In Review  |  Company News

Novartis halts price increases, reports 2Q earnings

Novartis AG (NYSE:NVS; SIX:NOVN) announced on July 18 that it will suspend for the rest of the year price increases in the U.S. The pharma made the announcement in conjunction with the release of its...
19:59 , Jul 18, 2018 |  BC Extra  |  Company News

Novartis halts price increases, reports 2Q earnings

Novartis AG (NYSE:NVS; SIX:NOVN) announced Wednesday that it will suspend for the rest of the year price increases in the U.S. The pharma made the announcement in conjunction with the release of its 2Q18 earnings....
18:57 , Jul 13, 2018 |  BC Week In Review  |  Company News

Novartis to spin out Alcon unit

Novartis AG (NYSE:NVS; SIX:NOVN) said it intends to spin out its Alcon eye care business, while retaining the pharma’s ophthalmology pharmaceuticals portfolio. The spinout will include Alcon’s surgical and vision care assets, which yielded $6.7...
20:52 , Jun 29, 2018 |  BC Extra  |  Company News

Novartis to spin out Alcon unit

Novartis AG (NYSE:NVS; SIX:NOVN) said it intends to spin out its Alcon eye care business, while retaining the pharma’s ophthalmology pharmaceuticals portfolio. The spinout will include Alcon’s surgical and vision care assets, which yielded $6.7...
00:37 , Jan 26, 2018 |  BC Extra  |  Politics & Policy

Narasimhan dines with Trump in Davos

Soon-to-be CEO of Novartis AG (NYSE:NVS; SIX:NOVN) Vasant Narasimhan attended a dinner with President Trump at the World Economic Forum in Davos, Switzerland on Thursday. The pharma declined to comment on what was discussed at...